Approval · Notice of Compliance 5014 · 1995
ESTRACE: Notice of Compliance 5014
Issued January 16, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5014
- Date
- January 16, 1995
- Company
- Roberts Pharmaceutical Canada Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Estrogen